BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21282353)

  • 1. Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases.
    Yang J; McEachern D; Li W; Davis MA; Li H; Morgan MA; Bai L; Sebolt JT; Sun H; Lawrence TS; Wang S; Sun Y
    Mol Cancer Ther; 2011 Apr; 10(4):658-69. PubMed ID: 21282353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis.
    Yang D; Zhao Y; Li AY; Wang S; Wang G; Sun Y
    Breast Cancer Res Treat; 2012 May; 133(1):189-99. PubMed ID: 21901386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential response of head and neck cancer cell lines to TRAIL or Smac mimetics is associated with the cellular levels and activity of caspase-8 and caspase-10.
    Raulf N; El-Attar R; Kulms D; Lecis D; Delia D; Walczak H; Papenfuss K; Odell E; Tavassoli M
    Br J Cancer; 2014 Nov; 111(10):1955-64. PubMed ID: 25314064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.
    Matzinger O; Viertl D; Tsoutsou P; Kadi L; Rigotti S; Zanna C; Wiedemann N; Vozenin MC; Vuagniaux G; Bourhis J
    Radiother Oncol; 2015 Sep; 116(3):495-503. PubMed ID: 26096848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
    Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
    Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tat-SmacN7 induces radiosensitization in cancer cells through the activation of caspases and induction of apoptosis.
    Chen F; Xu C; Du L; Wang Y; Cao J; Fu Y; Guo Y; Liu Q; Fan F
    Int J Oncol; 2013 Mar; 42(3):985-92. PubMed ID: 23338568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway.
    Sun Q; Zheng X; Zhang L; Yu J
    Clin Cancer Res; 2011 Apr; 17(8):2361-72. PubMed ID: 21242120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.
    Eytan DF; Snow GE; Carlson S; Derakhshan A; Saleh A; Schiltz S; Cheng H; Mohan S; Cornelius S; Coupar J; Sowers AL; Hernandez L; Mitchell JB; Annunziata CM; Chen Z; Van Waes C
    Cancer Res; 2016 Sep; 76(18):5442-5454. PubMed ID: 27469115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PS-341 and histone deacetylase inhibitor synergistically induce apoptosis in head and neck squamous cell carcinoma cells.
    Kim J; Guan J; Chang I; Chen X; Han D; Wang CY
    Mol Cancer Ther; 2010 Jul; 9(7):1977-84. PubMed ID: 20571067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smac mimetic compound LCL161 sensitizes esophageal carcinoma cells to radiotherapy by inhibiting the expression of inhibitor of apoptosis protein.
    Qin Q; Zuo Y; Yang X; Lu J; Zhan L; Xu L; Zhang C; Zhu H; Liu J; Liu Z; Tao G; Dai S; Zhang X; Ma J; Cai J; Sun X
    Tumour Biol; 2014 Mar; 35(3):2565-74. PubMed ID: 24170321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
    Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
    Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP.
    Lu J; Bai L; Sun H; Nikolovska-Coleska Z; McEachern D; Qiu S; Miller RS; Yi H; Shangary S; Sun Y; Meagher JL; Stuckey JA; Wang S
    Cancer Res; 2008 Nov; 68(22):9384-93. PubMed ID: 19010913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation.
    McComb S; Cheung HH; Korneluk RG; Wang S; Krishnan L; Sad S
    Cell Death Differ; 2012 Nov; 19(11):1791-801. PubMed ID: 22576661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment.
    Lu J; McEachern D; Sun H; Bai L; Peng Y; Qiu S; Miller R; Liao J; Yi H; Liu M; Bellail A; Hao C; Sun SY; Ting AT; Wang S
    Mol Cancer Ther; 2011 May; 10(5):902-14. PubMed ID: 21372226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
    Hannes S; Abhari BA; Fulda S
    Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis.
    Dai Y; Liu M; Tang W; DeSano J; Burstein E; Davis M; Pienta K; Lawrence T; Xu L
    Clin Cancer Res; 2008 Dec; 14(23):7701-10. PubMed ID: 19047096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer Effect of Ursodeoxycholic Acid in Human Oral Squamous Carcinoma HSC-3 Cells through the Caspases.
    Pang L; Zhao X; Liu W; Deng J; Tan X; Qiu L
    Nutrients; 2015 May; 7(5):3200-18. PubMed ID: 25951128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species-dependent EndoG release mediates cisplatin-induced caspase-independent apoptosis in human head and neck squamous carcinoma cells.
    Kim JS; Lee JH; Jeong WW; Choi DH; Cha HJ; Kim DH; Kwon JK; Park SE; Park JH; Cho HR; Lee SH; Park SK; Lee BJ; Min YJ; Park JW
    Int J Cancer; 2008 Feb; 122(3):672-80. PubMed ID: 17955488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpeptidic and potent small-molecule inhibitors of cIAP-1/2 and XIAP proteins.
    Sun H; Lu J; Liu L; Yi H; Qiu S; Yang CY; Deschamps JR; Wang S
    J Med Chem; 2010 Sep; 53(17):6361-7. PubMed ID: 20684551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.